Friday, 16 October 2026European Markets

NEDAP And LINEDATA SERVICES Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(vianews) - nedap (nedap.as) is among this list of stock assets with the highest dividend rate and return on equity on the technology sector.

financial asset price forward dividend yield return on equity
nedap (nedap.as) €68.00 4.75% 25.89%
linedata services (lin.pa) €68.00 3.38% 18.38%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. nedap (nedap.as)

4.75% forward dividend yield and 25.89% return on equity

nedap n.v., together with its subsidiaries, develops and supplies smart technological solutions in the netherlands, germany, rest of europe, north america, and internationally. the company provides software services that allow healthcare institutions in planning, registering, and administering care; and rfid solutions for inventory management, simplified shop processes, and prevention of shrinkage, that includes id cloud app, as well as develops and markets technological solutions for individual animal monitoring and management for the dairy farming industry. in addition, the company provides access control and security systems for companies and institutions. the company was founded in 1929 and is headquartered in groenlo, the netherlands.

earnings per share

as for profitability, nedap has a trailing twelve months eps of €3.29.

pe ratio

nedap has a trailing twelve months price to earnings ratio of 20.67. meaning, the purchaser of the share is investing €20.67 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.89%.

volatility

nedap's last week, last month's, and last quarter's current intraday variation average was 0.49%, 0.07%, and 0.90%.

nedap's highest amplitude of average volatility was 1.09% (last week), 0.75% (last month), and 0.90% (last quarter).

revenue growth

year-on-year quarterly revenue growth grew by 8.8%, now sitting on 262.43m for the twelve trailing months.

more news about nedap.

2. linedata services (lin.pa)

3.38% forward dividend yield and 18.38% return on equity

linedata services s.a. develops, publishes, and distributes financial software in southern europe, northern europe, north america, and asia. it operates through asset management and lending & leasing segments. the company provides solutions for asset managers and servicers, such as order management trading, investment compliance, risk management, and oversights; software for fund accounting, fund oversight, and transfer agency; analytics and data services; reconciliation solution and expense management; and investment data analytics and cognitive investment data management. it also offers solutions for lenders and lessors, such as commercial and syndicated lending, as well as for automotive, consumer, and equipment finance; and digitalization, marketplace, outsourced spreading, professional and hosting, and remarketing services, as well as business process as a service. in addition, the company provides advisory, risk and research, middle and office, and risk services, as well as technology solutions. linedata services s.a. was incorporated in 1998 and is headquartered in neuilly-sur-seine, france.

earnings per share

as for profitability, linedata services has a trailing twelve months eps of €4.03.

pe ratio

linedata services has a trailing twelve months price to earnings ratio of 16.87. meaning, the purchaser of the share is investing €16.87 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.38%.

yearly top and bottom value

linedata services's stock is valued at €68.00 at 16:30 est, way above its 52-week high of €60.40.

more news about linedata services.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com